Publications by authors named "A E el Bassiouny"
Background: Feeding intolerance is commonly experienced during enteral feeding, necessitating cessation. Metoclopramide may be given to assist gastric emptying, but patients experience adverse effects and gradual loss of efficacy. Prucalopride, a safer prokinetic, may play a role in gastric emptying.
View Article and Find Full Text PDFDiscovering effective anti-cancer agents poses a formidable challenge given the limited efficacy of current therapeutic modalities against various cancer types due to intrinsic resistance mechanisms. Cancer immunochemotherapy is an alternative strategy for breast cancer treatment and overcoming cancer resistance. Human Indoleamine 2,3-dioxygenase (hIDO1) and human Tryptophan 2,3-dioxygenase 2 (hTDO2) play pivotal roles in tryptophan metabolism, leading to the generation of kynurenine and other bioactive metabolites.
View Article and Find Full Text PDFArticle Synopsis
- A study aimed to use deep learning on brain MRI scans to predict 8-month survival rates for glioblastoma patients after radiotherapy, involving data from 206 patients diagnosed across UK centers.
- The model's performance was tested against both imaging data (from MRI scans) and non-imaging data (like demographics) and showed high accuracy, particularly with imaging data outperforming non-imaging data.
- This deep learning model can help identify glioblastoma patients at higher risk of early mortality, potentially guiding them towards early second-line treatments or clinical trials.
Background: The Pipeline Vantage Embolization Device (PEDV) is the fourth-generation pipeline flow diverter for intracranial aneurysm treatment. There are no outcome studies for the second PEDV version. We aimed to evaluate safety and efficacy outcomes.
View Article and Find Full Text PDFBackground: Hemodialysis (HD) patients commonly receive polypharmacy leading to increased likelihood of drug related problems (DRPs) and poor quality of life. Medication Therapy Management (MTM) services discover and resolve DRPs and may specifically improve Medication-burden Quality of life (MBQoL) in HD patients. We aimed to assess the effect of MTM services on DRPs and MBQoL among HD patients.
View Article and Find Full Text PDF